PROM1 and glioblastoma: Cho examined CBP4, a small peptide that exhibits an affinity for CD133, a biomarker of glioblastoma cancer stem cells (380) conjugated with gold nanoparticles demonstrating fluorescent signals, was used in glioblastoma imaging and diagnosis.